MAIGRET: a CRISPR-based immunoassay that employs antibody-induced cell-free transcription of CRISPR guide RNA strands
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Francesca Miceli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences and Technologies, University of Rome, Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy. Hauptthemen laut MEDLINE: RNA, Guide, CRISPR-Cas Systems, CRISPR-Cas Systems, Antibodies, Transcription, Genetic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of University and Research.
Abstract (Originalsprache)
Here we report on the development of a CRISPR-based assay for the sensitive and specific detection of antibodies and antigens directly in complex sample matrices. The assay, called Molecular Assay based on antibody-Induced Guide-RNA Enzymatic Transcription (MAIGRET), is based on the use of a responsive synthetic DNA template that triggers the cell-free in vitro transcription of a guide RNA strand upon recognition of a specific target antibody. Such transcribed guide RNA activates the DNA collateral activity of the Cas12a enzyme, leading to the downstream cleavage of a fluorophore/quencher-labeled reporter and thus resulting in an increase in the measured fluorescence signal. We have used MAIGRET for the detection of six different antibodies with high sensitivity (detection limit in the picomolar range) and specificity (no signal in the presence of non-target antibodies). MAIGRET can also be adapted to a competitive approach for the detection of specific antigens. With MAIGRET, we significantly expand the scope and applicability of CRISPR-based sensing approaches to potentially enable the measurement of any molecular target for which an antibody is available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences and Technologies, University of Rome, Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy.
- Department of Mechanical and Aerospace Engineering and of Bioengineering, University of California at Los Angeles, 420 Westwood Plaza, Los Angeles, CA 90095, United States.
- Istituto Nazionale Biostrutture e Biosistemi, INBB, Via dei Carpegna, 00165 Rome, Italy.
ORCID-Profile: Alessandro Porchetta, Francesco Ricci
Förderung
- European Research Council
- Associazione Italiana per la Ricerca sul Cancro
- Italian Ministry of University and Research
Zitieren
APA
Miceli, F., Bracaglia, S., Sorrentino, D., Porchetta, A., Ranallo, S., & Ricci, F. (2025). MAIGRET: a CRISPR-based immunoassay that employs antibody-induced cell-free transcription of CRISPR guide RNA strands. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf238
Vancouver
Miceli F, Bracaglia S, Sorrentino D, Porchetta A, Ranallo S, Ricci F. MAIGRET: a CRISPR-based immunoassay that employs antibody-induced cell-free transcription of CRISPR guide RNA strands. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf238
BibTeX
@article{Miceli2025,
author = {Miceli, Francesca and Bracaglia, Sara and Sorrentino, Daniela and Porchetta, Alessandro and Ranallo, Simona and Ricci, Francesco},
title = {MAIGRET: a CRISPR-based immunoassay that employs antibody-induced cell-free transcription of CRISPR guide RNA strands},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf238}
}
EUVIMED